Prokinetic drugs that stimulate 5-HT4-serotonin receptors in the human atrium
Naunyn-Schmiedeberg's Archives of Pharmacology · 2026
DOI: 10.1007/s00210-026-05659-1 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Joachim Neumann und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Pharmacology and Toxicology, Medical Faculty, Martin-Luther University Halle-Wittenberg, Magdeburger Straße 4, 06097, Halle (Saale), Ge…. Hauptthemen laut MEDLINE: Receptors, Serotonin, 5-HT4, Serotonin 5-HT4 Receptor Agonists, Heart Atria, Gastrointestinal Agents. Die Arbeit nennt 177 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Martin-Luther-Universität Halle-Wittenberg.
Abstract (Originalsprache)
Several gastrointestinal drugs like bromopride, cinitapride, cisapride, clebopride, felcisetrag, metoclopramide, mosapride, naronapride, prucalopride, renzapride, tegaserod, velusetrag, and zacopride are probably agonists at 5-HT 4 -serotonin receptors in the intestine. Some of these drugs do not act selectively only on 5-HT 4 -serotonin receptors. Instead, most of them also stimulate or inhibit other serotonin receptors. In addition, they sometimes stimulate or inhibit a wide variety of additional targets such as histamine receptors, adrenoceptors, dopamine receptors, monoamine transporters, or potassium channels. We review here to which extent these drugs are potent and/or effective agonists or antagonists at human cardiac 5-HT 4 -serotonin receptors. We address the possibility that at therapeutic concentrations some of these drugs may induce cardiac side effects via 5-HT 4 -serotonin receptors. Plasma concentrations of these drugs can sometimes be elevated by drug/drug interactions such that cardiac side effects become more likely. Moreover, we address the question whether such effects occur at the human cardiac atrium or at the human ventricle. We will focus on inotropic effects, but for completeness also address potential effects on the sinus node. We will present our view where there are remaining pre-clinical or clinical research needs. One may repurpose some of these drugs to act on cardiac 5-HT 4 -serotonin receptors and discuss for which indications this may offer additional benefits.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Pharmacology and Toxicology, Medical Faculty, Martin-Luther University Halle-Wittenberg, Magdeburger Straße 4, 06097, Halle (Saale), Germany. joachim.neumann@medizin.uni-halle.de.
- Institute for Pharmacology and Toxicology, Medical Faculty, Münster University, Domagkstraße 12, 48149, Münster, Germany.
- Department of Cardiac Surgery, Mid-German Heart Centre, University Hospital Halle, Ernst-Grube Straße 40, 06097, Halle (Saale), Germany.
- Institute for Pharmacology and Toxicology, Medical Faculty, Martin-Luther University Halle-Wittenberg, Magdeburger Straße 4, 06097, Halle (Saale), Germany.
Förderung
- Martin-Luther-Universität Halle-Wittenberg
Zitieren
APA
Neumann, J., Kirchhefer, U., Hofmann, B., & Gergs, U. (2026). Prokinetic drugs that stimulate 5-HT4-serotonin receptors in the human atrium. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-05659-1
Vancouver
Neumann J, Kirchhefer U, Hofmann B, Gergs U. Prokinetic drugs that stimulate 5-HT4-serotonin receptors in the human atrium. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-026-05659-1
BibTeX
@article{Neumann2026,
author = {Neumann, Joachim and Kirchhefer, Uwe and Hofmann, Britt and Gergs, Ulrich},
title = {Prokinetic drugs that stimulate 5-HT4-serotonin receptors in the human atrium},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
doi = {10.1007/s00210-026-05659-1}
}
EUVIMED